OTCMKTS:BSEM BioStem Technologies (BSEM) Stock Price, News & Analysis → President Kamala (From Stansberry Research) (Ad) Free BSEM Stock Alerts 7.35 +0.19 (+2.65%) (As of 06/14/2024 08:52 PM ET) Add Compare Share Share Today's Range7.06▼7.3550-Day Range7.16▼14.4052-Week Range1.20▼15.50Volume13,000 shsAverage Volume26,701 shsMarket Capitalization$119.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get BioStem Technologies alerts: Email Address Ad Stansberry ResearchPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White House is to bring back Barack Obama. And there's a sneaky (yet 100% legal) way to achieve this. In fact, this disaster scenario is already underway. See what they're up to, and how you can get ready today.Here's the full video exposé. About BioStem TechnologiesBioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.Read More BSEM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSEM Stock News HeadlinesMay 29, 2024 | globenewswire.comBioStem Technologies to Sponsor MRO Better Half DashMay 15, 2024 | finance.yahoo.comBSEM Again Bests Estimates as Growth AcceleratesMay 15, 2024 | finance.yahoo.comBioStem Technologies Inc (BSEM) Q1 2024 Earnings Call Transcript Highlights: A Remarkable ...May 14, 2024 | globenewswire.comBioStem Technologies Reports Record First Quarter Revenue of $41.9 MillionApril 30, 2024 | globenewswire.comBioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain AllograftsApril 24, 2024 | globenewswire.comBioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeApril 2, 2024 | finance.yahoo.comQ4 2023 Biostem Technologies Inc Earnings CallApril 2, 2024 | finance.yahoo.comBSEM Continues to Post Stellar ResultsApril 1, 2024 | globenewswire.comBioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY IncreaseMarch 21, 2024 | globenewswire.comBioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024March 9, 2024 | seekingalpha.comBSEM BioStem Technologies, Inc.March 9, 2024 | finance.yahoo.comBioStem Technologies, Inc. (BSEM)March 1, 2024 | morningstar.comBioStem Technologies Inc BSEMFebruary 6, 2024 | finance.yahoo.comBSEM: BioStem Expands and ImprovesFebruary 6, 2024 | finance.yahoo.comBSEM Provides Good Value for Great ScienceFebruary 6, 2024 | finance.yahoo.comBSEM Worth a Look on Surging RevenuesFebruary 6, 2024 | finance.yahoo.comBSEM Sees Increasing DemandFebruary 6, 2024 | finance.yahoo.comBSEM Crushes Estimates on Stellar GrowthFebruary 6, 2024 | finance.yahoo.comBSEM: Investors Need to Pay Attention to BSEMSee More Headlines Receive BSEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:BSEM Previous Symbol: CUSIPN/A CIK1658678 Webwww.biostemtechnologies.com Phone954-380-8342FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$16.68 million Price / Sales7.18 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares16,290,000Free FloatN/AMarket Cap$119.73 million OptionableN/A BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jason V. MatuszewskiCEO, President, Director & SecretaryMr. Michael A. Fortunato CPAChief Financial OfficerMr. Andrew VanvurstCOO & DirectorDr. David M. WoynarowskiChief Medical OfficerMr. Larry JonesChief Revenue OfficerDr. Irmgard Huber M.D.International Medical Advisor & Interim Chief Medical OfficerMr. Shawn F. McCarrey (Age 66)Chief Commercial Officer More ExecutivesKey CompetitorsEyePoint PharmaceuticalsNASDAQ:EYPTCorbus PharmaceuticalsNASDAQ:CRBPLexicon PharmaceuticalsNASDAQ:LXRXAcelyrinNASDAQ:SLRNContineum TherapeuticsNASDAQ:CTNMView All Competitors BSEM Stock Analysis - Frequently Asked Questions How have BSEM shares performed in 2024? BioStem Technologies' stock was trading at 7.35 on January 1st, 2024. Since then, BSEM stock has increased by 0.0% and is now trading at 7.35. View the best growth stocks for 2024 here. Are investors shorting BioStem Technologies? BioStem Technologies saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 40,700 shares, an increase of 38.9% from the May 15th total of 29,300 shares. Based on an average daily volume of 35,300 shares, the short-interest ratio is currently 1.2 days. View BioStem Technologies' Short Interest. How were BioStem Technologies' earnings last quarter? BioStem Technologies, Inc. (OTCMKTS:BSEM) released its quarterly earnings results on Tuesday, May, 14th. The company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.74 by $0.54. The company had revenue of $41.90 million for the quarter, compared to analyst estimates of $12.70 million. How do I buy shares of BioStem Technologies? Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BSEM) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
